Tag: provides

Wearable Devices Announces Full Year 2024 Financial Results and Provides Corporate Update

YOKNE’AM ILLIT, Israel, March 19, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd.…

GlobeNews Wire GlobeNews Wire
undefined

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

Southlake, TX, March 13, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS;…

GlobeNews Wire GlobeNews Wire
undefined

SCYNEXIS Reports Full Year 2024 Financial Resultsand Provides Corporate Update

March 12, 2025 17:08 ET  | Source: Scynexis The Phase 1 trial…

GlobeNews Wire GlobeNews Wire
undefined

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

March 03, 2025 09:27 ET  | Source: Pliant Therapeutics, Inc. SOUTH SAN…

GlobeNews Wire GlobeNews Wire
undefined

Longeveron Announces Full-Year 2024 Financial Results and Provides Business Update

Pivotal Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ (laromestrocel) in Hypoplastic Left…

GlobeNews Wire GlobeNews Wire
undefined

ALR Miner Provides Free Mining Contracts to Increase Passive Income

London, UK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- ALR Miner, a leading…

GlobeNews Wire GlobeNews Wire
undefined

Hydreight Technologies Provides Update to Financing

February 18, 2025 18:30 ET  | Source: Hydreight Technologies Inc. NOT FOR…

GlobeNews Wire GlobeNews Wire
undefined

Himax Technologies, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results; Provides First Quarter 2025 Guidance

Q4 2024 Revenues, Gross Margin and EPS All Surpassed Guidance Range Issued…

GlobeNews Wire GlobeNews Wire
undefined

Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01

STAFFORD, Texas, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq:…

GlobeNews Wire GlobeNews Wire
undefined

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trialin Patients with Idiopathic Pulmonary Fibrosis

February 07, 2025 16:58 ET  | Source: Pliant Therapeutics, Inc. Following DSMB…

GlobeNews Wire GlobeNews Wire
undefined